Biocon Campus - Biocon
Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion | The Financial Express
Biocon Biologics Limited | ISPE | International Society for Pharmaceutical Engineering
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Biocon - Wikipedia
Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets | Deccan Herald
Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News
Biocon logo in transparent PNG format
Research Centre - Biocon
Biocon - Crunchbase Company Profile & Funding
Biocon biosimilar plant criticized again by the FDA | Fierce Pharma
Biocon Biologics' antibody drug unit in Bengaluru gets EU GMP certificate | Business Standard News
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint
Joint drugs controller nabbed taking bribe to clear Biocon Biologics's diabetes injection | Mint
Biocon - 72 new faces joined us in February. Many... | Facebook
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Manufacturing Locations - Biocon
Biocon subsidiary acquires Viatris pharma for $3 billion | Mint
Research Centre - Biocon
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Biocon Campus - Biocon
Biocon sells 5.4% stake in its research arm Syngene International - Hindustan Times
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
India's Biocon Biologics to receive $150m from Goldman Sachs - Nikkei Asia
Biocon Q4 results show Consolidated revenue up by 21% - The Statesman
Manufacturing Operations - Biocon - Global Biopharmaceutical company
